Anti tubulin mab3408

Manufactured by Merck Group

Anti-tubulin (MAB3408) is a monoclonal antibody that recognizes the tubulin protein. It is commonly used in research applications to detect and study the tubulin cytoskeleton within cells.

Automatically generated - may contain errors

Lab products found in correlation

Anti kiaa0802 sc 84865, by Santa Cruz Biotechnology (2 mentions) Anti soga1 hpa043992, by Merck Group (2 mentions) Anti clasp2 sc 376496, by Santa Cruz Biotechnology (2 mentions) Anti giantin ab37266, by Abcam (2 mentions) Anti gcc185, by Fortis Life Sciences (2 mentions) Anti clasp1 mab9736, by Abnova (2 mentions) Anti akap450, by Novus Biologicals (2 mentions) Anti golgin97 d8p2k, by Cell Signaling Technology (2 mentions) Anti v5 r960 25, by Thermo Fisher Scientific (2 mentions) Anti flag f3165, by Merck Group (2 mentions) Anti pericentrin ab4448, by Abcam (2 mentions) Anti gapdh 5g4, by HyTest (2 mentions)

Close spelling variants of this product

Anti-tubulin (542 citations) MAB3408 (13 citations)

2 protocols using anti tubulin mab3408

Antibodies for Microtubule-associated Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols

To detect MTCL1 and MTCL2, anti-KIAA0802 (sc-84865) from Santa Cruz Biotechnology and anti-SOGA1 (HPA043992) from Sigma-Aldrich were used, respectively. To detect other proteins, the following antibodies were used: anti-α-tubulin (sc-32293), anti-acetylated tubulin (sc-23950), anti-MAP4 (sc-67152), anti-GFP (sc-9996) and anti-CLASP2 (sc-376496) from Santa Cruz Biotechnology; anti-V5 (R960-25) from Thermo Fisher Scientific; anti-GM130 (610822) and anti-GS28 (611184) from preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this this version posted September 7, 2021. ; https://doi.org/10.1101/2020.08.19.251967 doi: bioRxiv preprint BD Transduction Laboratories; anti-GAPDH (5G4) from HyTest Ltd.; anti-giantin (ab37266) and anti-pericentrin (ab4448) from Abcam; anti-GCC185 from Bethyl Laboratories; anti-Flag (F3165) from Sigma-Aldrich; anti--tubulin (MAB3408) from Merk Millipore; anti-CLASP1 (MAB9736) from Abnova; anti-AKAP450 from Novus Biologicals; anti-Golgin97 (D8P2K) from Cell Signaling Technology.

Matsuoka R., Miki M., Mizuno S., Ito Y., Yamada C., & Suzuki A. (2020). MTCL2 promotes asymmetric microtubule organization by crosslinking microtubules on the Golgi membrane.

+ Open protocol

+ Expand

Detecting MTCL1 and MTCL2 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols

To detect MTCL1 and MTCL2, anti-KIAA0802 (sc-84865) from Santa Cruz Biotechnology and anti-SOGA1 (HPA043992) from Sigma-Aldrich were used, respectively. To detect other proteins, the following antibodies were used: anti-α-tubulin (sc-32293), anti-acetylated tubulin (sc-23950), anti-MAP4 (sc-67152), anti-GFP (sc-9996) and anti-CLASP2 (sc-376496) from Santa Cruz Biotechnology; anti-V5 (R960-25) from Thermo Fisher Scientific; anti-GM130 (610822) and anti-GS28 (611184) from preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this this version posted September 7, 2021. ; https://doi.org/10.1101/2021.09.07.459224 doi: bioRxiv preprint BD Transduction Laboratories; anti-GAPDH (5G4) from HyTest Ltd.; anti-giantin (ab37266) and anti-pericentrin (ab4448) from Abcam; anti-GCC185 from Bethyl Laboratories; anti-Flag (F3165) from Sigma-Aldrich; anti--tubulin (MAB3408) from Merk Millipore; anti-CLASP1 (MAB9736) from Abnova; anti-AKAP450 from Novus Biologicals; anti-Golgin97 (D8P2K) from Cell Signaling Technology.

Matsuoka R., Miki M., Mizuno S., Ito Y., Yamada C., & Suzuki A. (2021). MTCL2 promotes asymmetric microtubule organization by crosslinking microtubules on the Golgi membrane.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!